Drug Pricing Executive Action Is Unlikely: Evercore ISI

There is significant chatter in Washington D.C. that U.S. President Barack Obama could use his executive authority to regulate drug pricing, a “flash note” from Evercore ISI analyst Terry Haines says. But such an action is unlikely for three primary reasons, says the research note delivered to institutional investors earlier Wednesday. Hot D.C. rumor: Obama may issue an executive order on drug prices The high profile cause comes as Martin Shkreli famously raised the price of a life saving aids drug by 5,500% — and then seemed to thumb his nose at Congress when he was called to testify. On…